|Articles|November 1, 1998

Chronic Viral Hepatitis in the Era of Managed Care
Volume 4
Issue 12 Suppl

Clinical Utility of HCV RNA Monitoring for Patients with Chronic Hepatitis C

Author(s)Lawrence M. Blatt, DrPH

Download PDF: Clinical Utility of HCV RNA Monitoring for Patients with Chronic Hepatitis C

Articles in this issue

over 27 years ago

Article

Participating Faculty

over 27 years ago

Article

An Overview of Viral Hepatitis

over 27 years ago

Article

Viral Hepatitis: Impact, Treatment, and Costs

over 27 years ago

Article

New Epidemiologic Data on Hepatitis B and C

over 27 years ago

Article

Appropriate Screening and Early Diagnosis of Hepatitis B and C

over 27 years ago

Article

State-of-the-Art Interferon Therapy for Chronic Viral Hepatitis

over 27 years ago

Article

Cost Effectiveness of Treating Chronic Hepatitis B and C

over 27 years ago

Article

Chronic Hepatitis C: An Overview

over 27 years ago

Article

Chronic Hepatitis C: Impact, Diagnosis, and Treatment

over 27 years ago

Article

Selected Abstracts

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Clinical Utility of HCV RNA Monitoring for Patients with Chronic Hepatitis C

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD

Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently

5 Ongoing Clinical Trials in Myeloproliferative Neoplasms

Defunding Co-Payment Assistance Disrupted nAMD Care

Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM